These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 20063558)
1. Clinical characteristics and outcome of pediatric patients with stage IV Hodgkin lymphoma. Belgaumi A; Al-Kofide AA; Khafaga Y; Joseph N; Jamil-Malik R; Siddiqui KS; Sabbah RS Hematol Oncol Stem Cell Ther; 2009; 2(1):278-84. PubMed ID: 20063558 [TBL] [Abstract][Full Text] [Related]
2. [A analysis of the outcome and prognostic factors in 415 patients with Hodgkin lymphoma]. Tao Y; Kang S; Zhou L; Shi Y; Li Y; Sun Y Zhonghua Zhong Liu Za Zhi; 2015 Jun; 37(6):466-71. PubMed ID: 26463153 [TBL] [Abstract][Full Text] [Related]
3. Contribution of involved-field radiotherapy to survival in patients with relapsed or refractory Hodgkin lymphoma undergoing autologous stem cell transplantation. Eroglu C; Kaynar L; Orhan O; Keklik M; Sahin C; Yildiz OG; Mentes S; Kurnaz F; Aslan D; Sivgin S; Soyuer S; Eser B; Cetin M; Unal A Am J Clin Oncol; 2015 Feb; 38(1):68-73. PubMed ID: 23563207 [TBL] [Abstract][Full Text] [Related]
4. Primary refractory Hodgkin's lymphoma: outcome after high-dose chemotherapy and autologous SCT and impact of various prognostic factors on overall and event-free survival. A single institution result of 66 patients. Akhtar S; El Weshi A; Abdelsalam M; Hussaini H; Janabi I; Rahal M; Maghfoor I Bone Marrow Transplant; 2007 Oct; 40(7):651-8. PubMed ID: 17660837 [TBL] [Abstract][Full Text] [Related]
5. Does bulky disease at diagnosis influence outcome in childhood Hodgkin's disease and require higher radiation doses? Results from the German-Austrian Pediatric Multicenter Trial DAL-HD-90. Dieckmann K; Pötter R; Hofmann J; Heinzl H; Wagner W; Schellong G; Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):644-52. PubMed ID: 12788169 [TBL] [Abstract][Full Text] [Related]
6. [Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma]. Niu Y; Shi YK; He XH; Feng FY; Zhou LQ; Gu DZ Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):630-4. PubMed ID: 19102946 [TBL] [Abstract][Full Text] [Related]
7. Nodular lymphocyte-predominant Hodgkin lymphoma characteristics, management of primary and relapsed/refractory disease and outcome analysis: the first comprehensive report from the Middle East. Akhtar S; Rauf MS; Khafaga Y; Al-Kofide A; Elhassan TAM; Elshenawy MA; Nadri J; Mushtaq AH; Bakshi N; Shamayel M; Al-Sweedan S; Sarwar S; Maghfoor I BMC Cancer; 2021 Apr; 21(1):351. PubMed ID: 33794818 [TBL] [Abstract][Full Text] [Related]
8. Analysis of prognostic factors after the first relapse of Hodgkin's disease in 187 patients. Brice P; Bastion Y; Divine M; Nedellec G; Ferrant A; Gabarre J; Reman O; Lepage E; Fermé C Cancer; 1996 Sep; 78(6):1293-9. PubMed ID: 8826953 [TBL] [Abstract][Full Text] [Related]
13. Risk-adapted therapy with three or six cycles of doxorubicin/bleomycin/vinblastine/dacarbazine plus involved-field radiation therapy in Hodgkin lymphoma, based on prognosis at diagnosis and early response: results from the GATLA study. Pavlovsky S; Corrado C; Pavlovsky MA; Prates MV; Zoppegno L; Giunta M; Cerutti I; Palomino E; Pagani F; Lastiri F; Bar D; Bezares RF; Avila G Clin Lymphoma Myeloma Leuk; 2010 Jun; 10(3):181-5. PubMed ID: 20511162 [TBL] [Abstract][Full Text] [Related]
15. Treatment of advanced-stage massive mediastinal Hodgkin's disease: the case for combined modality treatment. Longo DL; Russo A; Duffey PL; Hubbard SM; Glatstein E; Hill JB; Jaffe ES; Young RC; DeVita VT J Clin Oncol; 1991 Feb; 9(2):227-35. PubMed ID: 1988570 [TBL] [Abstract][Full Text] [Related]
16. Hodgkin lymphoma in very young children: Clinical characteristics and outcome of treatment. Belgaumi A; Al-Kofide A; Joseph N; Jamil-Malik R; Khafaga Y; Sabbah R Leuk Lymphoma; 2008 May; 49(5):910-6. PubMed ID: 18464110 [TBL] [Abstract][Full Text] [Related]
17. [A retrospective analysis of the treatment results in Hodgkin's disease in a radiotherapy clinic]. Mjaaland I; Ganser D; Freitag EM; Bohndorf W Strahlenther Onkol; 1994 Sep; 170(9):516-23. PubMed ID: 7524173 [TBL] [Abstract][Full Text] [Related]
18. Survival analysis of patients with Hodgkin lymphoma who failed high dose chemotherapy and autologous stem cell transplant. Elshenawy MA; Shahzad Rauf M; Elhassan TAM; Maghfoor I; Akhtar S Ann Hematol; 2018 Jul; 97(7):1229-1240. PubMed ID: 29484455 [TBL] [Abstract][Full Text] [Related]
19. [Treatment results of stage IA Hodgkin lymphoma: a report of 97 cases]. Tan WY; Hu DS; Zeng FY; Song QB; Hu S; Wei L; Zhou LQ Ai Zheng; 2007 Dec; 26(12):1360-4. PubMed ID: 18076802 [TBL] [Abstract][Full Text] [Related]
20. Outcome and prognostic factors of pediatric patients with Hodgkin lymphoma: a single-center experience. Ali N; Mansour M; Khalil E; Ebeid E J Egypt Natl Canc Inst; 2023 Sep; 35(1):29. PubMed ID: 37691044 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]